Fig. 2From: Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndromeThe curve of MLL-PTD expression levels post-transplantation. A Receiver operating characteristic (ROC) curve of MLL-PTD expression post-transplantation (AUC = 0.977, P < 0.001). B The level changes of post-transplant MLL-PTDBack to article page